|
C21ORF91 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.182800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.989000E-01 |
| Normal-vs-Stage2 |
9.915000E-01 |
| Normal-vs-Stage3 |
1.040390E-01 |
| Normal-vs-Stage4 |
7.936800E-01 |
| Stage1-vs-Stage2 |
6.748800E-01 |
| Stage1-vs-Stage3 |
1.838620E-01 |
| Stage1-vs-Stage4 |
9.026800E-01 |
| Stage2-vs-Stage3 |
3.151800E-01 |
| Stage2-vs-Stage4 |
8.402000E-01 |
| Stage3-vs-Stage4 |
4.909400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.575800E-01 |
| Normal-vs-AfricanAmerican |
1.454230E-02 |
| Normal-vs-Asian |
5.019600E-01 |
| Caucasian-vs-AfricanAmerican |
2.734100E-02 |
| Caucasian-vs-Asian |
5.179600E-01 |
| AfricanAmerican-vs-Asian |
6.878000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.132600E-01 |
| Normal-vs-Female |
3.192000E-01 |
| Male-vs-Female |
6.650200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.799400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.079400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.163600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.565800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.207010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.601800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.242800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.242100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.073520E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.812820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.964000E-01 |
| Normal-vs-Grade 2 |
9.772800E-01 |
| Normal-vs-Grade 3 |
3.520200E-01 |
| Normal-vs-Grade 4 |
7.181700E-03 |
| Grade 1-vs-Grade 2 |
8.699000E-01 |
| Grade 1-vs-Grade 3 |
5.160000E-01 |
| Grade 1-vs-Grade 4 |
1.194610E-01 |
| Grade 2-vs-Grade 3 |
2.820000E-01 |
| Grade 2-vs-Grade 4 |
1.818280E-03 |
| Grade 3-vs-Grade 4 |
9.890400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.235000E-01 |
| Normal-vs-ccB subtype |
2.046400E-01 |
| ccA subtype-vs-ccB subtype |
8.000200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.462200E-01 |
| Normal-vs-N1 |
1.073440E-01 |
| N0-vs-N1 |
3.507200E-01 |
|
|
